Author:
Burger Robert A.,Deng Wei,Makker Vicky,Collins Yvonne,Gray Heidi,Debernardo Robert,Martin Lainie P.,Aghajanian Carol
Funder
National Cancer Institute
Gynecologic Oncology Group Statistical Office
NRG Oncology
NRG Operations
Subject
Obstetrics and Gynecology,Oncology
Reference29 articles.
1. Cancer statistics, 2017;Siegel;CA Cancer J. Clin.,2017
2. Signatures of mutational processes in human cancer;Alexandrov;Nature,2013
3. TP53 mutation-mediated genomic instability induces the evolution of chemoresistance and recurrence in epithelial ovarian cancer;Zhang;Diagn. Pathol.,2017
4. OCEANS: a randomized, double-blind, placebo-controlled phase III trial of chemotherapy with or without bevacizumab in patients with platinum-sensitive recurrent epithelial ovarian, primary peritoneal, or fallopian tube cancer;Aghajanian;J. Clin. Oncol.,2012
5. Incorporation of bevacizumab in the primary treatment of ovarian cancer;Burger;N. Engl. J. Med.,2011
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献